<DOC>
	<DOCNO>NCT02514252</DOCNO>
	<brief_summary>The goal clinical research study learn investigational dose fentanyl sublingual spray ( FSS ) help control pain patient advance cancer give outpatient inpatient setting .</brief_summary>
	<brief_title>Sublingual Fentanyl Management Breakthrough Pain</brief_title>
	<detailed_description>Study Visits Study Drug Administration : This study 2 stage . Stage 1 complete inpatient unit hospital Stage 2 complete discharged hospital . Stage 1 : While hospital , pain episode , research nurse give single dose current pain medication exist infusion pump . You ask rate current level pain . You also ask side effect 15 minute 30 minute dose administer . You also complete 4 test mental ability 30 minute . If 1-4 hour another episode pain , give single dose FSS . You spray FSS tongue hold 30-60 second swallow . You ask current level pain 15 minute 30 minute dose FSS . You also complete 4 test mental ability 30 minute . If feel pain relief 30 minute , spray FSS 1 time tongue repeat pain mental ability test . If still feel pain relief 4 hour last dose FSS , spray double dose FSS tongue 2 time pain level mental ability test 15 30 minute dose . You may receive FSS 4 time total hospital . After last dose FSS , complete questionnaire symptom receive FSS . This take 2 minute complete . End Stage 1 : If FSS able help control pain , stop take FSS go back receive regular pain medication rest hospital stay . When discharged hospital , continue Stage 2 study ( describe ) receive FSS 4 week home . Before sent home , also prescribe pain medication take addition FSS , need . Your doctor explain take medication discharge . If FSS able help control pain , participation study end continue treat standard pain medication . Stage 2 : If take part Stage 2 , use FSS first choice pain medication instead oral pain medication pain 4 week . At time pain episode , spray FSS tongue . You always choice use pain medication doctor prescribe backup every 2 hour need pain . However , important NOT use oral pain medication time FSS . If still pain take FSS , must wait least 2 hour use pain medication . After 2 hour another episode pain , may use another dose FSS pain relief . Do take 4 dos FSS day . You give patient diary write day pain level , many time use FSS , side effect may . You call least 2 time week member study staff discuss diary answer question may . The study staff also ask pain medication use besides FSS , easy think use FSS , effective think FSS , satisfy current pain medication . Each phone call last 10 minute . After Day 28 , complete questionnaire phone opinion research study . This take 5 minute complete . Length Study : Your active participation study complete last questionnaire . You take study intolerable side effect occur unable follow study direction . Follow-Up : About 30 day study visit , call study staff ask feeling side effect may . This call last 10 minute . This investigational study . FSS FDA approve commercially available treatment pain cancer patient . It consider investigational use dose FSS use study use FSS inpatient outpatient setting . About 30 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Breakthrough Pain</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>1 . Patients advanced cancer ( locally advance , metastatic , recurrent and/or incurable cancer ) . 2 . Opioid tolerant , take daily dos strong opioid pain medication past 1 week . 3 . On strong opioid intravenous continuous infusion MEDD &gt; =70 mg/day time enrollment . 4 . Inpatient MD Anderson see palliative care team . 5 . Background cancer pain &lt; =3/10 last 24 hour . 6 . Breakthrough cancer pain &gt; =4/10 last 24 hour . 7 . Stable pain control define rescue dos &lt; =6 last 24 hour . 8 . Age &gt; =18 9 . Ability communicate English 1 . Memorial Delirium Assessment Scale &gt; 13/30 2 . History opioid abuse 3 . CAGE positivity ( &gt; =2/4 ) 4 . Allergy fentanyl 5 . Grade 2 high oral mucositis 6 . Unable/unwilling sign consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Advanced Cancers</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Recurrent cancer</keyword>
	<keyword>Incurable cancer</keyword>
	<keyword>Fentanyl sublingual spray</keyword>
	<keyword>FSS</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
	<keyword>Mental ability test</keyword>
	<keyword>Phone call</keyword>
	<keyword>Study diary</keyword>
	<keyword>Pain control</keyword>
</DOC>